Development of a fully-automated on-line oxidation column-switching HPLC system for the determination of endogenous melatonin in human clinical samples

Tsubasa Oyama, Rie Nagai, Mayumi Fujimoto, Ryoko Konishi, Masashi Mita, Keiko Uezono, Kiyoshi Zaitsu, Kenji Hamase

研究成果: ジャーナルへの寄稿記事

5 引用 (Scopus)

抄録

A fully-automated on-line oxidation column-switching HPLC system has been developed for the determination of endogenous melatonin in human plasma and saliva. This HPLC system consists of four processes. In the first step, melatonin is fractionated using a reversed-phase C4 column (Proteonavi, 75 mm × 1.0 mm i.d.). In the second step, the obtained melatonin fraction is on-line collected, and oxidized to a highly-fluorescent compound, N-[(6-methoxy-4-oxo- 1,4-dihydroquinolin-3-yl)methyl]acetamide (6-MOQMA), by mixing with hydrogen peroxide under alkaline conditions. In the third step, the produced 6-MOQMA is concentrated, and the oxidation reagents are removed using an alkaline resistive reversed-phase column, Asahipak ODP (35 mm × 1.0 mm i.d.). In the final fourth step, the 6-MOQMA is determined by a microbore-ODS column packed with ultrafine particles (CAPCELL PAK C18 IF, 250 mm × 1.0 mm i.d.). The limit of detection of melatonin using this system is about 200 amol/injection, and the determination of endogenous melatonin in a small volume of human physiological fluids, such as 100 μL of plasma and 300 μL of saliva, was successfully accomplished.

元の言語英語
ページ(範囲)1129-1135
ページ数7
ジャーナルanalytical sciences
31
発行部数11
DOI
出版物ステータス出版済み - 1 1 2015

Fingerprint

Switching systems
Melatonin
Oxidation
Plasma (human)
Hydrogen Peroxide
Plasmas
Fluids

All Science Journal Classification (ASJC) codes

  • Analytical Chemistry

これを引用

Development of a fully-automated on-line oxidation column-switching HPLC system for the determination of endogenous melatonin in human clinical samples. / Oyama, Tsubasa; Nagai, Rie; Fujimoto, Mayumi; Konishi, Ryoko; Mita, Masashi; Uezono, Keiko; Zaitsu, Kiyoshi; Hamase, Kenji.

:: analytical sciences, 巻 31, 番号 11, 01.01.2015, p. 1129-1135.

研究成果: ジャーナルへの寄稿記事

Oyama, Tsubasa ; Nagai, Rie ; Fujimoto, Mayumi ; Konishi, Ryoko ; Mita, Masashi ; Uezono, Keiko ; Zaitsu, Kiyoshi ; Hamase, Kenji. / Development of a fully-automated on-line oxidation column-switching HPLC system for the determination of endogenous melatonin in human clinical samples. :: analytical sciences. 2015 ; 巻 31, 番号 11. pp. 1129-1135.
@article{c724140d4562430cb56f877988a8d071,
title = "Development of a fully-automated on-line oxidation column-switching HPLC system for the determination of endogenous melatonin in human clinical samples",
abstract = "A fully-automated on-line oxidation column-switching HPLC system has been developed for the determination of endogenous melatonin in human plasma and saliva. This HPLC system consists of four processes. In the first step, melatonin is fractionated using a reversed-phase C4 column (Proteonavi, 75 mm × 1.0 mm i.d.). In the second step, the obtained melatonin fraction is on-line collected, and oxidized to a highly-fluorescent compound, N-[(6-methoxy-4-oxo- 1,4-dihydroquinolin-3-yl)methyl]acetamide (6-MOQMA), by mixing with hydrogen peroxide under alkaline conditions. In the third step, the produced 6-MOQMA is concentrated, and the oxidation reagents are removed using an alkaline resistive reversed-phase column, Asahipak ODP (35 mm × 1.0 mm i.d.). In the final fourth step, the 6-MOQMA is determined by a microbore-ODS column packed with ultrafine particles (CAPCELL PAK C18 IF, 250 mm × 1.0 mm i.d.). The limit of detection of melatonin using this system is about 200 amol/injection, and the determination of endogenous melatonin in a small volume of human physiological fluids, such as 100 μL of plasma and 300 μL of saliva, was successfully accomplished.",
author = "Tsubasa Oyama and Rie Nagai and Mayumi Fujimoto and Ryoko Konishi and Masashi Mita and Keiko Uezono and Kiyoshi Zaitsu and Kenji Hamase",
year = "2015",
month = "1",
day = "1",
doi = "10.2116/analsci.31.1129",
language = "English",
volume = "31",
pages = "1129--1135",
journal = "Analytical Sciences",
issn = "0910-6340",
publisher = "The Japan Society for Analytical Chemistry",
number = "11",

}

TY - JOUR

T1 - Development of a fully-automated on-line oxidation column-switching HPLC system for the determination of endogenous melatonin in human clinical samples

AU - Oyama, Tsubasa

AU - Nagai, Rie

AU - Fujimoto, Mayumi

AU - Konishi, Ryoko

AU - Mita, Masashi

AU - Uezono, Keiko

AU - Zaitsu, Kiyoshi

AU - Hamase, Kenji

PY - 2015/1/1

Y1 - 2015/1/1

N2 - A fully-automated on-line oxidation column-switching HPLC system has been developed for the determination of endogenous melatonin in human plasma and saliva. This HPLC system consists of four processes. In the first step, melatonin is fractionated using a reversed-phase C4 column (Proteonavi, 75 mm × 1.0 mm i.d.). In the second step, the obtained melatonin fraction is on-line collected, and oxidized to a highly-fluorescent compound, N-[(6-methoxy-4-oxo- 1,4-dihydroquinolin-3-yl)methyl]acetamide (6-MOQMA), by mixing with hydrogen peroxide under alkaline conditions. In the third step, the produced 6-MOQMA is concentrated, and the oxidation reagents are removed using an alkaline resistive reversed-phase column, Asahipak ODP (35 mm × 1.0 mm i.d.). In the final fourth step, the 6-MOQMA is determined by a microbore-ODS column packed with ultrafine particles (CAPCELL PAK C18 IF, 250 mm × 1.0 mm i.d.). The limit of detection of melatonin using this system is about 200 amol/injection, and the determination of endogenous melatonin in a small volume of human physiological fluids, such as 100 μL of plasma and 300 μL of saliva, was successfully accomplished.

AB - A fully-automated on-line oxidation column-switching HPLC system has been developed for the determination of endogenous melatonin in human plasma and saliva. This HPLC system consists of four processes. In the first step, melatonin is fractionated using a reversed-phase C4 column (Proteonavi, 75 mm × 1.0 mm i.d.). In the second step, the obtained melatonin fraction is on-line collected, and oxidized to a highly-fluorescent compound, N-[(6-methoxy-4-oxo- 1,4-dihydroquinolin-3-yl)methyl]acetamide (6-MOQMA), by mixing with hydrogen peroxide under alkaline conditions. In the third step, the produced 6-MOQMA is concentrated, and the oxidation reagents are removed using an alkaline resistive reversed-phase column, Asahipak ODP (35 mm × 1.0 mm i.d.). In the final fourth step, the 6-MOQMA is determined by a microbore-ODS column packed with ultrafine particles (CAPCELL PAK C18 IF, 250 mm × 1.0 mm i.d.). The limit of detection of melatonin using this system is about 200 amol/injection, and the determination of endogenous melatonin in a small volume of human physiological fluids, such as 100 μL of plasma and 300 μL of saliva, was successfully accomplished.

UR - http://www.scopus.com/inward/record.url?scp=84958754890&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958754890&partnerID=8YFLogxK

U2 - 10.2116/analsci.31.1129

DO - 10.2116/analsci.31.1129

M3 - Article

C2 - 26561256

AN - SCOPUS:84958754890

VL - 31

SP - 1129

EP - 1135

JO - Analytical Sciences

JF - Analytical Sciences

SN - 0910-6340

IS - 11

ER -